Trials / Completed
CompletedNCT02518191
Effects of GnRHa on Ovarian Function Against Chemotherapy-induced-gonadotoxicity
Effects of GnRHa on Ovarian Function Against Chemotherapy-induced-gonadotoxicity in Women With Breast Cancer in China
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 345 (actual)
- Sponsor
- Xiangyun Zong · Academic / Other
- Sex
- Female
- Age
- 18 Years – 49 Years
- Healthy volunteers
- Not accepted
Summary
This prospective randomized controlled study is conducted to analyze the effect of Goserelin on ovarian function in women with breast cancer in China.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GnRHa | 3.6mg subcutaneous injection every 28 days.Initiated 1-2 weeks before chemotherapy and ended 4-8 weeks after chemotherapy. |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2021-01-12
- Completion
- 2021-01-12
- First posted
- 2015-08-07
- Last updated
- 2021-06-11
- Results posted
- 2021-05-03
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02518191. Inclusion in this directory is not an endorsement.